1. Home
  2. BOSC vs RNTX Comparison

BOSC vs RNTX Comparison

Compare BOSC & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOSC
  • RNTX
  • Stock Information
  • Founded
  • BOSC 1990
  • RNTX 2001
  • Country
  • BOSC Israel
  • RNTX United States
  • Employees
  • BOSC N/A
  • RNTX N/A
  • Industry
  • BOSC Computer Communications Equipment
  • RNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOSC Telecommunications
  • RNTX Health Care
  • Exchange
  • BOSC Nasdaq
  • RNTX Nasdaq
  • Market Cap
  • BOSC 29.6M
  • RNTX 28.0M
  • IPO Year
  • BOSC 1996
  • RNTX N/A
  • Fundamental
  • Price
  • BOSC $4.95
  • RNTX $1.18
  • Analyst Decision
  • BOSC
  • RNTX Hold
  • Analyst Count
  • BOSC 0
  • RNTX 1
  • Target Price
  • BOSC N/A
  • RNTX N/A
  • AVG Volume (30 Days)
  • BOSC 70.4K
  • RNTX 133.3K
  • Earning Date
  • BOSC 08-21-2025
  • RNTX 11-13-2025
  • Dividend Yield
  • BOSC N/A
  • RNTX N/A
  • EPS Growth
  • BOSC 55.92
  • RNTX N/A
  • EPS
  • BOSC 0.52
  • RNTX N/A
  • Revenue
  • BOSC $46,768,000.00
  • RNTX N/A
  • Revenue This Year
  • BOSC N/A
  • RNTX N/A
  • Revenue Next Year
  • BOSC N/A
  • RNTX N/A
  • P/E Ratio
  • BOSC $9.25
  • RNTX N/A
  • Revenue Growth
  • BOSC 15.66
  • RNTX N/A
  • 52 Week Low
  • BOSC $2.50
  • RNTX $1.04
  • 52 Week High
  • BOSC $5.50
  • RNTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • BOSC 57.30
  • RNTX 47.69
  • Support Level
  • BOSC $4.65
  • RNTX $1.08
  • Resistance Level
  • BOSC $4.91
  • RNTX $1.25
  • Average True Range (ATR)
  • BOSC 0.16
  • RNTX 0.14
  • MACD
  • BOSC 0.02
  • RNTX -0.01
  • Stochastic Oscillator
  • BOSC 50.00
  • RNTX 28.30

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

Share on Social Networks: